Holen Sie sich die Stockscreener-App
4.31
0.00%
0.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.31
Offen:
$4.29
24-Stunden-Volumen:
128.19K
Relative Volume:
0.60
Marktkapitalisierung:
$132.02M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-3.0786
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
+12.24%
1M Leistung:
+10.51%
6M Leistung:
-22.34%
1J Leistung:
-58.32%
1-Tages-Spanne:
$4.155
$4.32
1-Wochen-Bereich:
$3.52
$4.43
52-Wochen-Spanne:
$3.22
$10.50
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.31 | 132.02M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Hochstufung | BTIG Research | Sell → Neutral |
| 2025-08-08 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
| 2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-27 | Eingeleitet | BofA Securities | Buy |
| 2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally - GlobeNewswire Inc.
RCEL: D. Boral Capital Maintains "Buy" Rating and $10 PT | RCEL Stock News - GuruFocus
Avita Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Broker tips 25% upside for this ASX healthcare stock following FY25 earnings results - MSN
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth - Investing.com Nigeria
Avita's Road to Profitability Is in Sight - Morningstar
AVITA Medical to Host Investor Webinar Briefing - Investing News Network
Ask AVITA Medical’s interim CEO your questions in Feb. 18 investor webinar Q&A - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Avita Medical (RCEL) TTM US$48.6m Loss Tests Bullish Profitability Narratives - Sahm
Avita Medical Q4 2025 slides: 11% annual growth with 12-19% expansion targeted for 2026 - Investing.com Canada
AVITA Medical (RCEL) Reports Strong Q4 2025 Performance - GuruFocus
Avita Medical Q4 Earnings Call Highlights - MarketBeat
AVITA Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
AVITA Medical (RCEL) Q4 2025 Earnings Transcript - The Globe and Mail
Avita Medical (RCEL) Reports Lower Q4 Revenue Amidst Operational Transition - GuruFocus
Avita Medical earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
AVITA Medical to Announce Q4 Earnings on February 12 - Intellectia AI
Avita Medical (NASDAQ:RCEL) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
AVITA Medical, Inc. SEC 10-K Report - TradingView
AVITA Medical Q4 Earnings Summary & Key Takeaways - Benzinga
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
AVITA Medical Inc (AVHHL) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
Lake Street raises price target on AVITA Medical, Inc. (RCEL) to $3.50, maintains hold rating - MSN
Is AVITA Medical Inc. forming a bullish divergenceEarnings Recap Summary & Fast Entry and Exit Trade Plans - mfd.ru
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Is AVITA Medical Inc. stock a buy before product launchesTrade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
Aug Volume: What is the dividend yield of GOOSJuly 2025 EndofMonth & Verified Entry Point Signals - baoquankhu1.vn
Lake Street Raises Price Target on AVITA Medical, Inc. (RCEL) to $3.50, Maintains Hold Rating - Finviz
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
AVITA Medical, Inc.'s (NASDAQ:RCEL) Shift From Loss To Profit - Yahoo Finance
Avita Medical Stock: Skin Regeneration Platform Is Set Up For A Turnaround (NASDAQ:RCEL) - Seeking Alpha
Buy Signal: Can AVITA Medical Inc weather a recession2025 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Insider Buy: Is Ellomay Capital Ltd a speculative investmentPortfolio Risk Report & High Conviction Trade Alerts - baoquankhu1.vn
Aug Summary: What is NVAWWs P E ratio telling usMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
AVITA Medical (RCEL) Analyst Rating: Maintained 'Buy' with $10 P - GuruFocus
D. Boral Capital Reaffirms Buy Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
New Highs: Will AVITA Medical Inc benefit from rate cuts2025 Year in Review & Safe Capital Allocation Plans - baoquankhu1.vn
AVITA Medical (RCEL) Showcases Breakthrough Data at 2026 Burn Sy - GuruFocus
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies - Investing News Network
First three-part AVITA burn care path cuts painful dressing changes - stocktitan.net
There's No Escaping AVITA Medical, Inc.'s (NASDAQ:RCEL) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
Momentum Shift: Can AVITA Medical Inc maintain sales growth2025 Key Lessons & Low Drawdown Trading Strategies - baoquankhu1.vn
Volatility Watch: Is AVITA Medical Inc stock forming a triangle patternWeekly Profit Analysis & Scalable Portfolio Growth Methods - baoquankhu1.vn
AVITA Medical, Inc.'s (NASDAQ:RCEL) Path To Profitability - simplywall.st
RCEL Analyst Rating Update: Lake Street Raises Price Target | RC - GuruFocus
AVITA Medical (ASX:AVH) Posts Revenue Growth and Advances Clinical Pipeline Ahead of Key Data in 2026 - Kalkine Media
AVITA Medical (RCEL): Analyst Lowers Price Target, Maintains Buy Rating | RCEL Stock News - GuruFocus
D. Boral Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
RCEL: 2026 guidance targets $80–$85M revenue, driven by clinical innovation and focused execution - TradingView — Track All Markets
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):